Skip to main content
. Author manuscript; available in PMC: 2019 Sep 1.
Published in final edited form as: Perfusion. 2018 Apr 11;33(6):472–482. doi: 10.1177/0267659118766436

Table 1.

Description of Cohort.

Overall (N = 481)1
Age
 Pre-term neonate 44 (9.1%)
 Full-term neonate 203 (42.2%)
 Infant 114 (23.7%)
 Child 77 (16.0%)
 Adolescent 43 (8.9%)
Male 283 (58.8%)
Race
 White 232 (48.2%)
 Black or African American 87 (18.1%)
 Other 26 (5.4%)
 Unknown/Not Reported 136 (28.3%)
Hispanic or Latino 82 (17.0%)
Infection prior to or during the first 24 hours of ECMO
 None 235 (48.9%)
 Suspected 148 (30.8%)
 Bacterial 49 (10.2%)
 Viral 32 (6.7%)
 Fungal 6 (1.2%)
 Multiple 11 (2.3%)
Location of ECMO care
 PICU 100 (20.8%)
 NICU 151 (31.4%)
 CICU 230 (47.8%)
Mode of ECMO
 VA 400 (83.2%)
 VV 81 (16.8%)
Baseline Vasoactive Inotropic Score2
 None 140 (29.1%)
 Low 155 (32.2%)
 High 186 (38.7%)
Primary ECMO indication
 Respiratory 229 (47.6%)
 Cardiac 184 (38.3%)
 ECPR 68 (14.1%)

ECMO: extracorporeal membrane oxygenation; PICU: pediatric intensive care unit; NICU: neonatal intensive care unit; CICU: cardiac intensive care unit; VA: venoarterial; VV: venovenous; ECPR: extracorporeal cardiopulmonary resuscitation.

1

Data are expressed as counts and column percentages.

2

None is Vasoactive Inotropic Score (VIS) =0, low is VIS >0 and <20 and high is VIS ≥20.